CTNM Net Income

Annual Net Income

$22.72 M
+$46.97 M+193.68%

December 31, 2023


Summary


Performance

CTNM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTNMprofitabilitymetrics:

Quarterly Net Income

-$10.27 M
-$1.26 M-13.96%

September 30, 2024


Summary


Performance

CTNM Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTNMprofitabilitymetrics:

TTM Net Income

-$35.46 M
-$4.02 M-12.77%

September 30, 2024


Summary


Performance

CTNM TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTNMprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CTNM Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+193.7%-32.1%-256.1%
3 y3 years+178.3%-36.7%-372.1%
5 y5 years+178.3%-36.7%-372.1%

CTNM Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+178.3%-124.7%at low-221.3%at low
5 y5-yearat high+178.3%-124.7%at low-221.3%at low
alltimeall timeat high+178.3%-124.7%at low-221.3%at low

Contineum Therapeutics Class A Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$10.27 M(+14.0%)
-$35.46 M(+12.8%)
Jun 2024
-
-$9.01 M(+7.0%)
-$31.45 M(-264.4%)
Mar 2024
-
-$8.42 M(+8.3%)
$19.13 M(-15.8%)
Dec 2023
$22.72 M
-$7.77 M(+24.3%)
$22.72 M(-1.1%)
Sep 2023
-
-$6.25 M(-115.0%)
$22.98 M(-21.4%)
DateAnnualQuarterlyTTM
Jun 2023
-
$41.56 M(-961.6%)
$29.23 M(-336.9%)
Mar 2023
-
-$4.82 M(-35.8%)
-$12.34 M(+64.2%)
Dec 2022
-$24.25 M(-16.4%)
-
-
Dec 2022
-
-$7.51 M
-$7.51 M
Dec 2021
-$29.00 M
-
-

FAQ

  • What is Contineum Therapeutics Class A annual net profit?
  • What is the all time high annual net income for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A annual net income year-on-year change?
  • What is Contineum Therapeutics Class A quarterly net profit?
  • What is the all time high quarterly net income for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A quarterly net income year-on-year change?
  • What is Contineum Therapeutics Class A TTM net profit?
  • What is the all time high TTM net income for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A TTM net income year-on-year change?

What is Contineum Therapeutics Class A annual net profit?

The current annual net income of CTNM is $22.72 M

What is the all time high annual net income for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high annual net profit is $22.72 M

What is Contineum Therapeutics Class A annual net income year-on-year change?

Over the past year, CTNM annual net profit has changed by +$46.97 M (+193.68%)

What is Contineum Therapeutics Class A quarterly net profit?

The current quarterly net income of CTNM is -$10.27 M

What is the all time high quarterly net income for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high quarterly net profit is $41.56 M

What is Contineum Therapeutics Class A quarterly net income year-on-year change?

Over the past year, CTNM quarterly net profit has changed by -$2.50 M (-32.15%)

What is Contineum Therapeutics Class A TTM net profit?

The current TTM net income of CTNM is -$35.46 M

What is the all time high TTM net income for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high TTM net profit is $29.23 M

What is Contineum Therapeutics Class A TTM net income year-on-year change?

Over the past year, CTNM TTM net profit has changed by -$58.18 M (-256.08%)